Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy.
Yin L, Li XY, Zhu LL, Chen GL, Xiang Z, Wang QQ, Bi JW, Wang Q.
Yin L, et al. Among authors: zhu ll.
Front Immunol. 2022 Sep 5;13:965120. doi: 10.3389/fimmu.2022.965120. eCollection 2022.
Front Immunol. 2022.
PMID: 36131929
Free PMC article.
Review.
Previous clinical studies indicated that ablation treatment activated immune responses besides killing tumor cells directly, such as short-term anti-tumor response, immunosuppression reduction, specific and non-specific immune enhancement, and the reduction or disappearanc …
Previous clinical studies indicated that ablation treatment activated immune responses besides killing tumor cells directly, such as short- …